LucenceINSIGHT
Prescription blood-based multi-cancer early detection family using ctDNA and viral DNA with machine-learning tissue localization.
- Developer
- Lucence
- Intended use
- Multi Cancer Screening
- Cancer scope
- Breast cancer, Colorectal cancer, Liver cancer, Lung cancer, Pancreatic cancer, Thyroid cancer
- Specimen
- Whole blood
- Molecular modality
- DNA
- Current version
- LucenceINSIGHT current U.S. family (Core / Me / 12, 2026)
- Evidence context
- 1 structured studies · 6 indexed performance results · 3 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.